We are live on
!
Find out more
MRSN
Mersana Therapeutics
MRSN
MRSN
Delisted
MRSN was delisted on the 5th of January, 2026.
113 hedge funds and large institutions have $219M invested in Mersana Therapeutics in 2024 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 39 increasing their positions, 32 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
22% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 32
0.05% more ownership
Funds ownership: 3.73% → 3.78% (+0.05%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less capital invested
Capital invested by funds: $230M → $219M (-$10.1M)
6% less funds holding
Funds holding: 120 → 113 (-7)
35% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 17
37% less call options, than puts
Call options by funds: $770K | Put options by funds: $1.23M
Holders
113
Holders Change
-7
Holders Change %
-5.83%
% of All Funds
1.62%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
11
Increased
39
Reduced
32
Closed
17
Calls
$770K
Puts
$1.23M
Net Calls
-$460K
Net Calls Change
-$704K
Top Buyers
| 1 |
NI
Nextech Invest
Zurich,
Switzerland
|
+$4.48M |
| 2 |
BC
Boxer Capital
San Diego,
California
|
+$3.21M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$2.94M |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
+$2.28M |
| 5 |
EAM
Exome Asset Management
New York
|
+$2.08M |
Top Sellers
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$5.23M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
-$1.82M |
| 3 |
Renaissance Technologies
New York
|
-$1.69M |
| 4 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$1.61M |
| 5 |
Morgan Stanley
New York
|
-$1.6M |
